Cargando…
Effector Tregs: middle-men in TGFβ activation
Autores principales: | Worthington, John J., Travis, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652975/ https://www.ncbi.nlm.nih.gov/pubmed/26158637 |
Ejemplares similares
-
Integrin αvβ8-Mediated TGF-β Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation
por: Worthington, John J., et al.
Publicado: (2015) -
The Yin and Yang of Targeting KLRG1(+) Tregs and Effector Cells
por: Borys, Samantha M., et al.
Publicado: (2022) -
Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3(+) Tregs
por: Chen, Xin, et al.
Publicado: (2021) -
TGF-β1 Drives Inflammatory Th Cell But Not Treg Cell Compartment Upon Allergen Exposure
por: Musiol, Stephanie, et al.
Publicado: (2022) -
The Different Functional Distribution of “Not Effector” T Cells (Treg/Tnull) in Colorectal Cancer
por: Niccolai, Elena, et al.
Publicado: (2017)